Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 370.50
Bid: 365.00
Ask: 374.50
Change: 3.50 (0.95%)
Spread: 9.50 (2.603%)
Open: 374.00
High: 374.00
Low: 363.00
Prev. Close: 367.00
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Information on AGM

15 Feb 2016 07:00

RNS Number : 0018P
Banco Santander S.A.
12 February 2016
 

material fact

 

The board of directors of Banco Santander, S.A. at its meeting held today has resolved to call the shareholders to the next ordinary general shareholders' meeting to be held in Santander, at the Palacio de Exposiciones y Congresos (Avenida del Racing, s/n), on 17 March 2016 at 9:30 a.m., on first call, or on 18 March 2016 at the same time, on second call, with the following agenda:

 

One.- Annual accounts and corporate management.

One A. Examination and, if appropriate, approval of the annual accounts (balance sheet, profit and loss statement, statement of recognised income and expense, statement of changes in total equity, cash flow statement, and notes) of Banco Santander, S.A. and its consolidated Group, all with respect to the Financial Year ended 31 December 2015.

One B. Examination and, if appropriate, approval of the corporate management for Financial Year 2015.

Two.- Application of results obtained during Financial Year 2015.

Three.- Board of directors: appointment, re-election or ratification of directors.

Three A. Ratification of appointment of Ms Belén Romana García.

Three B. Ratification of appointment of Mr Ignacio Benjumea Cabeza de Vaca.

Three C. Re-election of Ms Sol Daurella Comadrán.

Three D. Re-election of Mr Ángel Jado Becerro de Bengoa.

Three E. Re-election of Mr Javier Botín-Sanz de Sautuola y O'Shea.

Three F. Re-election of Ms Isabel Tocino Biscarolasaga.

Three G. Re-election of Mr Bruce Carnegie-Brown.

Four.- Appointment of the external auditor for Financial Years 2016, 2017 and 2018.

Five.- Amendment of the following articles of the Bylaws:

Five A. Amendment of article 23 (power and duty to call a meeting), related to the general shareholders' meeting.

Five B. Amendment of articles regarding the board of directors: article 40 (creation of shareholder value) and article 45 (secretary of the board).

Five C. Amendment of articles regarding the committees of the board: article 50 (committees of the board of directors), article 53 (audit committee), article 54 (appointments committee), article 54 bis (remuneration committee) and article 54 ter (risk supervision, regulation and compliance committee).

Six.- Amendment of the following articles of the Rules and Regulations for the General Shareholders' Meeting:

Six A. Amendment of article 6 (information available as of the date of the call to meeting), relating to the publication of information regarding the general shareholders' meeting.

Six B. Amendment of article 21 (voting on proposed resolutions), relating to the procedure at the general shareholders' meeting.

Seven.- Delegation to the board of directors of the power to carry out the resolution to be adopted by the shareholders at the meeting to increase the share capital pursuant to the provisions of section 297.1.a) of the Spanish Capital Corporations Law, depriving of effect the authorisation conferred under resolution Seven II) adopted at the ordinary general shareholders' meeting of 27 March 2015.

Eight.- Increase in share capital by such amount as may be determined pursuant to the terms of the resolution, by means of the issuance of new ordinary shares having a par value of one-half (0.5) euro each, with no share premium, of the same class and series as those that are currently outstanding, with a charge to reserves. Offer to acquire bonus share rights (derechos de asignación gratuita) at a guaranteed price. Express provision for the possibility of less than full allotment. Delegation of powers to the board of directors, which may in turn delegate such powers to the executive committee, to establish the terms and conditions of the increase as to all matters not provided for by the shareholders at this general shareholders' meeting, to take such actions as may be required for implementation thereof, to amend the text of sections 1 and 2 of article 5 of the Bylaws to reflect the new amount of share capital, and to execute such public and private documents as may be necessary to carry out the increase. Application to the appropriate domestic and foreign authorities for admission to trading of the new shares on the Madrid, Barcelona, Bilbao and Valencia Stock Exchanges through Spain's Automated Quotation System (Mercado Continuo) and on the foreign Stock Exchanges on which the shares of Banco Santander are listed (currently Lisbon, London, Milan, Warsaw, Buenos Aires, Mexico and New York through American Depositary Shares (ADSs), and São Paulo through Brazilian Depositary Receipts (BDRs)) in the manner required by each of such Stock Exchanges.

Nine.- Delegation to the board of directors of the power to issue non-convertible fixed-income securities, preferred interests or debt instruments of a similar nature (including certificates, promissory notes and warrants), rescinding to the extent of the unused amount the delegations in force conferred by the shareholders acting at previous general shareholders' meetings in such respect.

Ten.- Director remuneration policy.

Eleven.- Director remuneration system: setting of the maximum amount of total annual remuneration of directors in their capacity as directors.

Twelve.- Remuneration system: approval of maximum ratio between fixed and variable components of total remuneration of executive directors and other employees belonging to categories which professional activities impact significantly on the risk profile.

Thirteen.- Approval of the application of remuneration plans which entail the delivery of shares or options on shares:

Thirteen A. First cycle of the Deferred Multiyear Objectives Variable Remuneration Plan.

Thirteen B. Sixth cycle of the Deferred and Conditional Variable Remuneration Plan.

Thirteen C. Application of Santander Group's buy-out policy.

Thirteen D. Plan for employees of Santander UK plc. and other companies of the Group in the United Kingdom by means of options on shares of the Bank linked to the contribution of periodic monetary amounts and to certain continuity requirements.

Fourteen.- Authorisation to the board of directors to interpret, remedy, supplement, implement and develop the resolutions approved by the shareholders at the meeting, as well as to delegate the powers received from the shareholders at the meeting, and grant of powers to convert such resolutions into notarial instruments.

Fifteen.- Annual director remuneration report.(*)

(*) Consultative vote.

 

The relevant call of meeting will be published in the coming days.

 

Boadilla del Monte (Madrid), 12 February 2016

 

This document is a translation of an original text in Spanish. In case of any discrepancy between both texts, the Spanish version will prevail.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUAAPUPQPPP
Date   Source Headline
13th Jun 202411:05 amRNSBuyback programme: transactions 6-12Jun
7th Jun 20244:25 pmRNSDirector/PDMR Shareholding
6th Jun 202411:04 amRNSBuyback programme: transactions 30May-5Jun
31st May 20241:28 pmRNSTotal Voting Rights
30th May 202411:07 amRNSBuyback programme: transactions 23-29 May
29th May 202411:11 amRNSForm 8.3 - Spirent Communications plc
23rd May 202411:10 amRNSBuyback programme: transactions 17-22 May
17th May 202411:19 amRNSBuyback programme: transactions 8-16 May
16th May 20243:13 pmRNSInvitation to buy outstanding preferred securities
14th May 202411:33 amRNSUnauthorized access to 3rd party-hosted database
10th May 202411:53 amRNSDirector/PDMR Shareholding
8th May 202411:07 amRNSBuyback programme: transactions 26 Apr-7 May
8th May 20247:00 amRNSInvitation to buy outstanding preferred securities
7th May 20247:10 amRNSInvitation to buy outstanding preferred securities
7th May 20247:00 amRNSDirector/PDMR Shareholding
30th Apr 20241:01 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNS1Q 2024 results report & earnings presentation
30th Apr 20247:00 amRNSFirst Quarter 2024 Results - Press release
26th Apr 202411:28 amRNSBuyback programme: transactions 18-25 Apr
23rd Apr 202411:03 amRNSNotice of First Quarter 2024 Results
18th Apr 202411:04 amRNSBuyback programme: transactions 11-17 Apr
11th Apr 202411:07 amRNSBuyback programme: transactions 3-10 Apr
3rd Apr 202411:10 amRNSBuyback programme: transactions 21Mar-2Apr
2nd Apr 20245:07 pmRNSTotal Voting Rights
22nd Mar 20242:27 pmRNS2024 AGM - Resolutions
22nd Mar 20247:00 amRNSSantander is on its track to meet its 2024 targets
21st Mar 202410:52 amRNSBuyback programme: transactions 14-20 Mar
19th Mar 20249:47 amRNS2023 UK Annual Report
18th Mar 20245:46 pmRNSDirector/PDMR Shareholding
18th Mar 20245:37 pmRNSDirector/PDMR Shareholding
18th Mar 20245:26 pmRNSDirector/PDMR Shareholding
14th Mar 202411:04 amRNSBuyback programme: transactions 7-13 Mar
12th Mar 20249:30 amRNSForm 8.3 - Spirent Communications plc
7th Mar 202411:05 amRNSBuyback programme: transactions 29 Feb-6 Mar
29th Feb 20242:50 pmRNSTotal Voting Rights
29th Feb 202411:07 amRNSBuyback programme: transactions 20-28 Feb
27th Feb 20245:15 pmRNSDirector/PDMR Shareholding
27th Feb 20245:13 pmRNSDirector/PDMR Shareholding
27th Feb 20245:12 pmRNSDirector/PDMR Shareholding
21st Feb 20243:33 pmRNSDirector/PDMR Shareholding
20th Feb 20247:00 amRNSNotice of AGM
19th Feb 202411:17 amRNSDividend approval & buyback program implementation
19th Feb 20247:45 amRNSFurther re dividend approval
19th Feb 20247:43 amRNSDividend approval & buyback program implementation
7th Feb 20244:39 pmRNSDirector/PDMR Shareholding
7th Feb 20244:38 pmRNSDirector/PDMR Shareholding
7th Feb 20244:36 pmRNSDirector/PDMR Shareholding
5th Feb 20245:48 pmRNSFurther re capital reduction
1st Feb 20244:46 pmRNSDirector/PDMR Shareholding
31st Jan 20243:55 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.